Infectious Disease Modelling in Public Health Policy: Current status and challenges
Slides (Nikos Demiris) Slides (Marc Baguelin) Slides (Katrin Haeussler) Slides (Ines Guerra & Lucille Marie) Slides (Eli Gajaraj)
| Date | 4 July 2016 |
| Time | 10:00 – 17:00 |
| Event | One day workshop |
| Location | Department of Statistical Science. |
This workshop aims at discussing the methodological status quo in infectious disease modelling and the potential issues associated with its extension to an economic (rather than a purely epidemiological) context. The workshop will consist of three sessions devoted to current challenges to the full implementation of health economic modelling of infectious diseases from the technical, industry, and regulatory perspective.
The workshop will be held at UCL, Anatomy G29 J. Z. Young Lecture Theatre on July 4th. The schedule for the day is the following.
9.30-10.00: Reception and coffee
Part 1: Methodological perspective
- 10.00-10.30: Welcome and challenges in infectious disease modelling for economic evaluation. Gianluca Baio (UCL)
- 10.30-11.15: Basic Concepts of Epidemic Models. Nikos Demiris (Athens University of Economics and Business)
- 11.15-11.30: Coffee break
- 11.30-12.15: Reconstruction of influenza transmission dynamics and optimal vaccination strategies. Marc Baguelin (London School of Hygiene and Tropical Medicine)
- 12.15-13.00: Bayesian Dynamic Markov models for health economic evaluations of interventions in infectious disease. Katrin Haussler (UCL)
- 13.00-13.30: Lunch break
Part 2: Industry perspective
- 13:30-14:00: Transmission vs. non-transmission models for the submission of new drugs for infectious diseases. Ines Guerra and Lucile Marie (Mapi)
- 14:00-14:30: Vaccine Modelling - Perspective and Challenges for Industry in the UK. Ian Matthews (Sanofi Pasteur MSD)
- 14:30–15:00: Do the differences between vaccines and drug treatment imply a different approach in health economic assessment? Baudouin Standaert (GSK)
- 15:00–15:15: Coffee break
Part 3: Reimbursement perspective
- 15:15-16:00: What makes a model “fit for purpose”: The experience of NICE. Elangovan Gajraj (NICE)
- 16:00-16:45: The use of modelling based cost effectiveness evidence by the Department of Health to inform immunisation and wider policy. Peter Grove (Department of Health, Health Protection Analytical Team)
- 16:45–17:00: Discussion
- 17:00–17:15: Closing remarks. Andreas Karabis (Mapi)